Effects of Y1 receptor agonist on the pancreatic islet of diet-induced obese and diabetic mice-Reference-Cited by-同舟云学术

Effects of Y1 receptor agonist on the pancreatic islet of diet-induced obese and diabetic mice

Published:2020-09 Issue:9 Volume:34 Page:107669
ISSN:1056-8727
Container-title:Journal of Diabetes and its Complications
language:en
Short-container-title:Journal of Diabetes and its Complications

Author:

Carapeto Priscila Viana,Mandarim-de-Lacerda Carlos A.,Aguila Marcia Barbosa

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference40 articles.

1. Pancreatic regulation of glucose homeostasis;Roder;Exp Mol Med,2016

2. L’îlot pancréatique : ce que nous savons 150 ans après Langerhans;Mandarim-de-Lacerda;Bull Acad Nationale Méd (France),2019

3. Mandarim-de-Lacerda CA. Pancreatic islet (of Langerhans) revisited. Histol Histopathol. 2019; 34(9): 985–993 (doi: 10.14670/HH-18-118).

4. Chen Y, Huang L, Qi X, Chen C. Insulin Receptor Trafficking: Consequences for Insulin Sensitivity and Diabetes. Int J Mol Sci. 2019; 20(20): (doi: https://doi.org/10.3390/ijms20205007).

5. Erion K, Corkey BE. beta-Cell Failure or beta-Cell Abuse? Frontiers in endocrinology. 2018; 9: 532 (doi: https://doi.org/10.3389/fendo.2018.00532).

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cross talk about the role of Neuropeptide Y in CNS disorders and diseases;Neuropeptides;2023-12

2. Established and emerging roles peptide YY (PYY) and exploitation in obesity–diabetes;Current Opinion in Endocrinology, Diabetes & Obesity;2020-12-30